Search
Contineum Therapeutics Inc
CTNMAdd to Watchlist
15.100USD
-0.140-0.92%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
564.53MMarket Cap
LossP/E TTM
Institutional Confidence
Currency: USD Updated: 2026-07-02The current institutional shareholding score of Contineum Therapeutics Inc is 10.00, ranking 1 out of 387 in the Biotechnology & Medical Research industry. The latest institutional shareholding proportion is 91.13%, representing a quarter-over-quarter increase of 22.20%. The largest institutional shareholder is Steven Cohen, holding a total of 82.59K shares, representing 0.23% of shares outstanding, with 11.33% decrease in holdings.